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Abstract Isopenicillin N synthase (IPNS) from Aspergillus
nidulans is a no-heme iron(II)-dependent oxygenase which
catalyses, in a single reaction, the bicyclisation of N-(L-K-
aminoadipoyl)-L-cysteinyl-D-valine into isopenicillin N, the pre-
cursor of all other penicillins, cephalosporins and cephamycins.
The IPNS reaction can be followed directly and continuously by
a new assay which monitors the absorbance increase at 235 nm
characteristic of penicillin nucleus formation. Using this assay,
the effects of influential factors affecting the in vitro IPNS
enzymatic reaction were investigated. Even under optimal
conditions, enzyme inactivation occurred during catalysis.
Iron(II) depletion and product inhibition were not the cause of
this phenomenon, the addition of antioxidants or reducing agents
failed to slow down inactivation or reactivate the enzyme.
Therefore, this phenomenon appears to be irreversible and is
attributed to oxidative damage caused to the enzyme by reactive
oxygen species generated in solution during catalysis. Never-
theless, the steady-state kinetic parameters for the IPNS
reaction were determined. ß 2000 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
L-Lactam antibiotics are widely used compounds for the
treatment of bacterial infectious diseases. Various L-lactam-
producing microorganisms are used in fermentation processes
to directly produce penicillin antibiotics, or starting materials,
such as benzylpenicillin or cephalosporin C, which are trans-
formed by synthesis into other antibiotics.
Isopenicillin N synthase (IPNS) is a key enzyme in the
L-lactam biosynthetic pathway. It catalyses the bicyclisation
of N-(L-K-aminoadipoyl)-L-cysteinyl-D-valine (ACV) into iso-
penicillin N (IPN), the precursor of all other penicillins, ceph-
alosporins and cephamycins [1].
One catalytic turnover proceeds through two oxidative ring
closures in which four hydrogen atoms are removed from the
tripeptide substrate and one molecule of dioxygen is trans-
formed into two water molecules (Fig. 1). IPNS uses a single
ferrous iron to capture and activate the oxidative molecular
oxygen [2] and is a member of an extended family of mono-
nuclear no-heme iron(II)-dependent oxygenases [3,4]. Signi¢-
cant homology is observed between the primary structures of
IPNS and of an extended subgroup of this family, the 2-oxo-
glutarate-dependent oxygenases. This subgroup includes en-
zymes involved in the cephem biosynthesis pathway and an-
other related enzyme, 1-aminocyclopropane-1-carboxylic acid
oxidase (ACCO) [5], which, like IPNS, does not utilise a
2-oxoglutarate cosubstrate. The primary structure isology is
re£ected in the folding similarities observed between the ter-
tiary structures of IPNS and deacetoxycephalosporin C syn-
thase (DAOCS) [6,7].
Under certain conditions, the IPNS reaction can be studied
in vitro using cell-free extracts or puri¢ed enzyme from vari-
ous microorganisms. Among the discontinuous techniques
employed to follow IPNS activity are the hole-plate bioassay
[8,9], high performance liquid chromatography (HPLC) [10]
and nuclear magnetic resonance [11,12]. However, these meth-
ods can be time consuming, labour intensive and tedious to
perform when many samples are analysed. Two procedures,
which allow a continuous monitoring of IPNS activity, an
automatic pH titration-coupled enzyme assay using a L-lac-
tamase [13] and an oxygen uptake assay [14] have been de-
scribed. Whilst these methods are more appealing, they require
special technical skills and careful setting and calibration of
the experimental conditions. Moreover, the precision of the
oxygen uptake assay is reduced owing to a background rate
due to competing non-speci¢c oxidation reactions.
We have developed a continuous spectrophotometric assay
for IPNS based on the increased absorbance at 235 nm due to
penicillin formation. It is readily performed and was used here
to determine steady-state parameters and investigate the in£u-
ence of the various cofactors on the in vitro IPNS enzymatic
reaction.
2. Materials and methods
ACV was synthesised and the TEM-L-lactamase prepared as de-
scribed [15,16]. All other chemicals were purchased from Sigma-Al-
drich. A homogeneous preparation of recombinant wild-type Asper-
gillus nidulans IPNS [11] was used throughout this study.
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2.1. Preparation of ACV stock solution
Stock solutions of 10 to 20 mM ACV were made in distilled water
and the pH adjusted to neutrality. ACV contains a thiol group and
readily oxidises in solution into its disul¢de form which is not an
IPNS substrate. Thus, it is necessary to incubate the ACV stock so-
lution with an equimolar amount of reducing agent before preparing
the assay mixture. With tris(carboxyethyl)phosphine (TCEP), reaction
for 10 min at 25‡C was su⁄cient to reduce all the disul¢des present.
An independent determination of the ACV concentration in stock
solution was made using the method described by Le and Means [17].
2.2. HPLC assay
IPNS activity was determined by monitoring IPN production. A
standard assay mixture consisted of 200 Wl of 50 mM HEPES (pH
7.0) containing up to 10 mM ACV, 1 mM TCEP, 100 WM ascorbate,
25 WM iron(II) and 0.5^4 WM IPNS enzyme. These values were modi-
¢ed in some of the experiments as indicated in the text or the ¢gure
legends. After 5^10 min at 30‡C, the reaction was stopped by addition
of an equal volume of 0.5 mM o-phenanthroline and kept on ice or
stored at 320‡C. The samples were centrifuged for 5 min at 10 000Ug
prior to injection (20^50 Wl). Separation of the products was per-
formed by reversed-phase HPLC on a 250U4 mm Merck Lichrospher
RP18 100-5 Wm column using a linear elution gradient of 2^25%
acetonitrile in 25 mM sodium phosphate bu¡er pH 7.0 (1 ml/min).
UV detection was at 215 nm.
2.3. Spectrophotometric assay of IPNS
UV spectrophotometric measurements were made in 1 cm light-
path quartz cuvettes with a Beckman DU8 instrument interfaced
with a computer for data collection or with a Hewlett-Packard
HP8452A diode array spectrophotometer. Freshly prepared assay
mixtures were prepared by dilution of stock solutions of ACV and
other cofactors and contained 50 mM HEPES (pH 7.0), 1 mM TCEP
and 25 WM ascorbate. The ACV concentration ranged from 0.2 to 10
mM. In practice, 2^3 ml mixes for each ACV concentration were
made and kept on ice. Before running the assay, a small volume of
concentrated ferrous ammonium sulphate solution was added (10 to
25 WM ¢nal concentration). The concentration of dioxygen in aqueous
solution is dependent on the temperature and is about 0.23 mM at
30‡C (21% in air at 0.1 MPa). Thus, the cofactors mixture was equil-
ibrated for several minutes at the assay temperature before proceed-
ing. A sample (450 Wl) was withdrawn, added with concentrated IPNS
enzyme solution (0.5^2 WM ¢nal concentration), and the absorbance
at 235 nm recorded. During the measurement, the temperature was
maintained at 30‡C by a Peltier system. Under these conditions, initial
rates are proportional to the enzyme concentration and can be calcu-
lated from the linear portion in the early part of the reaction time
course. A blank assay (no enzyme) was similarly recorded and if a
signi¢cant linear change in absorbance was observed, probably due to
iron(II)-catalysed oxidation of ascorbate [18], the values obtained in
the presence of enzyme were accordingly corrected. The rate values in
the text and ¢gures were obtained from at least four independent
measurements and one blank assay for each condition or ACV con-
centration tested.
2.4. Determination of vO associated with ACV conversion to IPN
The total change in absorbance at 235 nm was recorded for six
standard spectrophotometric assays of 450 Wl samples containing
200 or 400 WM ACV. The reactions were stopped with o-phenanthro-
line and the amount of IPN accumulated in these samples was deter-
mined with the DD-peptidase assay [19]. This provided a value of
1130 þ 50 M31 cm31 for the variation of the molar absorption coef-
¢cient associated with the formation of IPN.
3. Results
3.1. Development of the spectrophotometric assay
The largest variation in the UV absorption spectrum ob-
served during IPNS catalysis is found at 235 nm. A good
agreement was found between the amount of IPN accumu-
lated in the samples as determined by the HPLC and DD-
peptidase assays and the recorded change in absorbance
(Fig. 2). The absorbance progress curve indicates a rapid con-
version of substrate followed by a decrease in rate leading to a
¢nal plateau. Excessive substrate utilisation can be ruled out
as the cause of non-linearity since little IPN product is formed
under the conditions used in the experiment. Thus, the ob-
served non-linearity of the IPNS reaction rate is most likely
the result of a gradual enzyme inactivation and several factors
related to this phenomenon were investigated.
To examine product inhibition, two standard reaction sam-
ples were used, one of them containing a small amount of
TEM-L-lactamase to hydrolyse IPN as it was formed. While
no IPN peak was detected in the HPLC chromatogram of the
L-lactamase-containing sample, a similar ACV peak was
found in both samples. This result indicates that product in-
hibition is not the cause of the enzyme inactivation (data not
shown).
It is reasonable to suggest that depletion of iron(II) could
be responsible for this phenomenon. Fig. 3A depicts an ex-
periment in which new aliquots of iron(II) or IPNS enzyme
were added to reaction mixtures where almost complete en-
Fig. 1. Reaction catalysed by IPNS.
Fig. 2. IPNS activity determined with three di¡erent assay methods.
Standard assay: 2 ml of 50 mM HEPES, pH 7.0 containing 800
WM ACV, 1.2 mM TCEP, 25 WM ascorbate, 10 WM iron(II) and 0.5
WM IPNS. After the enzyme was added, the change of absorbance
at 235 nm was recorded on 450 Wl of the mixture. The remaining
solution was incubated at 30‡C and 120 Wl samples were removed
after ¢xed time periods, the reaction rapidly stopped by addition of
o-phenanthroline and the quantity of IPN determined by HPLC
(8) and DD-peptidase assays (7).
FEBS 24323 17-11-00
A. Dubus et al./FEBS Letters 485 (2000) 142^146 143
zyme inactivation had occurred. Fresh addition of iron did
not restore enzyme activity while addition of enzyme resulted
in a burst of product formation. Similarly, HPLC analysis of
samples removed before and 6 min after the respective addi-
tions (Fig. 3B) showed that iron addition did not result in an
IPN peak increase while enzyme addition did. These results
demonstrate that inactivation caused by iron(II) depletion can
be excluded but also that all the other assay components (i.e.
ACV, ascorbate and TCEP) are still functional and present in
su⁄cient quantity to promote IPNS activity.
In subsequent experiments, no recovery of enzyme activity
upon addition of two reducing agents, 1 mM TCEP or 5 mM
sodium dithionite, could be obtained in either case. Likewise,
addition of 200 WM t-butyl-4-hydroxyanisole or 100 WM ethyl
gallate, two substances known for their antioxidant proper-
ties, also did not result in any signi¢cant improvement of the
enzyme lifetime.
Therefore, if the enzyme inactivation results from an oxi-
dative process, the modi¢cation appears to be irreversible
under the conditions used.
3.2. In£uence of ascorbate on the IPNS reaction
The e¡ect of ascorbate on the in vitro IPNS reaction was
examined both by the HPLC and spectrophotometric assays
(Fig. 4). The HPLC assay was used initially, because of the
large UV absorbance associated with high ascorbate concen-
trations. In this experiment, the largest amount of IPN
formed after 20 min reached a plateau above 1 mM ascorbate,
corresponding to about three times the quantity obtained in
the absence of ascorbate. In the light of our previous results
(see Fig. 2) we can assume that the enzyme was completely
inactivated at the end of the 20 min incubation period.
In the spectrophotometric assays, lower ascorbate concen-
trations were used and initial reaction rates were directly mea-
sured on a much shorter time period (less than 1 min). The
maximum rate was observed at 0.2 mM ascorbate and repre-
sented less than twice the value obtained in the absence of
ascorbate. The discrepancy between these results is explained
by the di¡erent techniques and conditions and would prob-
ably be less marked if a shorter incubation period had been
used for the HPLC assay. But this would have rendered the
method less precise since less product would have been de-
tected. Nonetheless, both experiments indicate that ascorbate
has a positive e¡ect on the in vitro enzyme activity with di¡er-
ent in£uences on the magnitude of the turnover (initial rates)
Fig. 3. Reactivation experiments. The assay mixtures contained
1 mM ACV, 2 mM TCEP, 25 WM ascorbate in 50 mM HEPES,
pH 7.0 and additional compounds as indicated. A: Reaction fol-
lowed at 235 nm. The arrow indicates the moment when new addi-
tions of either iron or IPNS were made and the asterisks when ali-
quots were withdrawn for HPLC analysis. B: HPLC
chromatograms. The analyses performed at the end of the proce-
dures (upper trace) are shown with a 1.25 min o¡set to allow com-
parison of the results.
Fig. 4. E¡ect of ascorbate on IPNS activity. 8 : HPLC assay. 100
Wl reaction mixtures contained 2 mM ACV, 4 mM TCEP, 20 WM
iron(II), 1 WM IPNS in 50 mM HEPES (pH 7.0) and were incu-
bated for 20 min at 30‡C. 7 : Initial rates calculated from absor-
bance change. 450 Wl assay mixtures contained 250 WM ACV, 2 mM
TCEP, 25 WM iron(II), 0.5 WM IPNS in 50 mM HEPES, pH 7.0.
Relative values are the ratios of values measured at di¡erent ascor-
bate concentrations to those obtained in the absence of ascorbate
(i.e. v0 = 2.6 Wmol s31 Wmol31, [IPN]0 = 0.23 mM).
Fig. 5. Initial rate measurements as a function of ACV concentra-
tion. Initial rate values were determined with 400 Wl reaction mix-
tures containing ACV in 50 mM HEPES (pH 7.0), 1 mM TCEP, 25
WM ascorbate, 10 WM iron(II) and 1.22 WM IPNS. The curve results
from non-linear regression ¢tting of the data to the Henri^Michaelis
equation with kcat = 4.14 ( þ 0.11) s31 and Km = 120 ( þ 10) WM. In-
set: linear regression according to the Hanes^Woolf equation.
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and inactivation rates. The increase of the turnover rate
reaches an optimum value at 0.2 mM ascorbate and then
decreases back to its initial value as the concentration of as-
corbate increases. On the contrary, the amount of IPN formed
after 20 min, which also re£ects the enzyme stability, contin-
ues to increase up to 1 mM ascorbate.
3.3. Determination of steady-state kinetic parameters from
initial rate measurements
The plot of initial rates against ACV concentrations shows
that the enzyme reaction obeys simple saturation kinetics (Fig.
5). The steady-state kinetic parameters are kcat = 4.1 ( þ 0.11)
s31, Km = 120 ( þ 10) WM, speci¢c activity = 6.64 U per mgE
(1 U equals 1 Wmol/min). These values are signi¢cantly di¡er-
ent from those obtained previously with the same A. nidulans
enzyme using the HPLC assay [11] : kcat = 0.2 s31, Km = 1220
WM, speci¢c activity = 0.32 U per mgE (assay conditions: 50
mM Tris pH 8.0, 4 mM dithiothreitol (DTT), 1 mM ascor-
bate, 100 WM iron(II) and up to 100 WM IPNS; 5 min incu-
bation at 28‡C). The di¡erence in methodology and experi-
mental conditions must be the cause for the di¡erence
observed in the measured parameters. It is remarkable that
the present spectrophotometric assay yields a much larger
speci¢c activity meaning that either the assay conditions are
more favourable for enzyme activity or that this new method
supplies better estimates of the initial rates.
4. Discussion
Ferrous iron is an absolute requirement for IPNS catalytic
activity and its concentration in the assay bu¡er is inversely
proportional to the enzyme degree of purity. Spectrophoto-
metric initial rate determinations with puri¢ed enzyme (1 WM)
and 0.5 mM ACV in 50 mM HEPES, 2 mM TCEP, pH 7.0
were performed at iron to enzyme molar ratios ranging from
30 to 240 and no signi¢cant variation was observed. Ascor-
bate was omitted in these assays because its interaction with
iron would have unnecessarily complicated the interpretation
of the results. With puri¢ed enzyme a 25- to 50-fold iron
molar excess is su⁄cient for optimum activity and the mini-
mum amount necessary to activate the enzyme should be
used.
The utilisation of Tris as bu¡er generally rests on historical
reasons rather than on its intrinsic qualities. In fact, Tris
presents some problems such as a reactive primary amine
and metal chelating properties [20] which can have undesir-
able e¡ects. Consequently, we used HEPES bu¡er, but a re-
lated compound such as Mops is probably also well suited
[21]. However, as pointed out by others [22,23] there is no
ideal bu¡er when studying biochemical reactions involving a
transition metal.
At pH 6.0, the enzymatic activity of the Cephalosporium
acremonium IPNS is 10% of that observed at pH 8 [21]. Using
the spectrophotometric assay, with the recombinant A. nidu-
lans enzyme, there was no marked di¡erence between initial
rates measured at pH 7.0 and 7.5. However, the choice of a
pH value below 7.5 was chosen on the basis of the following
considerations. Above neutral pH ferric iron rapidly forms
insoluble polymeric hydroxyl complexes and this process has
two adverse e¡ects on the assay: it rapidly decreases the
amount of soluble iron(II) available to bind to IPNS, and
interferes with the spectrophotometric detection. For this rea-
son, phosphate bu¡er which dramatically increases the ferrous
iron oxidation rate should be avoided [22,24]. Moreover, in
solution the generally slow ‘auto-oxidation’ of thiols to their
disul¢de form by molecular oxygen is increased by trace
amounts of transition metals and is generally faster at alkaline
pH [22].
Early studies with cell-free extracts or partially puri¢ed
IPNS preparations showed that in vitro enzyme activity is
stimulated by the addition of DTT and ascorbate in the assay
bu¡er [9,21,25]. These reducing agents do not directly partic-
ipate in the catalytic mechanism and their role seems to be
restricted to maintaining both ACV and iron (either active site
bound or in solution) in their reduced states. It has been
suggested in the case of the related prolyl hydroxylase that
ascorbate could reduce in situ inactive Fe3^enzyme com-
plexes [26]. Another potential role for these substances rests
on their ability to scavenge fortuitous reactive oxygen species
(ROS, i.e. superoxide, hydrogen peroxide and hydroxyl radi-
cal) formed during the reaction and to prevent oxidative dam-
age to the enzyme [27].
The simultaneous presence of a transition metal, a reducing
agent and dioxygen can have very detrimental e¡ects on bio-
logical systems studied in vitro. In fact DTT, the most com-
monly used reducing agent, is known to ligate iron in a bi-
dentate manner and this complex favours the rapid metal-
catalysed oxidation of the dithiol in solution [23,24]. This
auto-oxidation reaction has two adverse e¡ects on the IPNS
assay: it utilises oxygen, a co-reactant in IPNS catalysis, and
generates ROS and sulfur radicals [23]. It has been shown that
reduced glutathione undergoes the same metal-catalysed auto-
oxidation phenomenon [28] and presumably ACV would be-
have similarly. TCEP is a soluble non-volatile phosphine,
which does not interact with iron in solution, is more stable
than DTT to oxidation and is a better reducing agent at pH
values below 7.5 [29,30]. The replacement of DTT by TCEP in
the IPNS assay bu¡er enhanced the enzyme activity probably
by removing some of the problems associated with DTT.
Ascorbate has been reported to stimulate most 2-oxogluta-
rate related and dependent oxygenases, but under certain con-
ditions to inhibit others, e.g. proline 4-hydroxylase [31]. It is
also known to exhibit prooxidant activities in the presence of
iron(II) [32]. When included in the IPNS assay mixture, as-
corbate appears to have a rather direct activating e¡ect on the
enzyme catalytic process which becomes inhibitory at higher
concentrations but it also exhibits a more indirect action
probably linked to its antioxidant protective properties which
increase the enzyme lifetime. Interestingly, with the C. acre-
monium enzyme it was observed that the shape of the progress
curves were similar with or without ascorbate but a ¢ve-fold
decrease in the amount of converted ACV was obtained in the
absence of ascorbate [21].
Nevertheless, even under optimal assay conditions, a pro-
gressive enzyme inactivation phenomenon still occurred. In-
stability under catalytic conditions had already been observed
with IPNS [21] and with related oxygenases such as DAOCS
[33], ACCO [34] or prolyl hydroxylase [26]. The mechanism
leading to inactivation remains to be elucidated but our re-
sults have ruled out certain causes such as iron depletion or
product inhibition. The formation of a dead-end complex
during catalysis seems to be unlikely as it is inconsistent
with the high e⁄ciency of the biosynthetic process. This in-
activation also could not be reversed by addition of reducing
FEBS 24323 17-11-00
A. Dubus et al./FEBS Letters 485 (2000) 142^146 145
agents. A likely explanation involves some irreversible oxida-
tive damage caused by ROS reacting with the backbone or the
side-chain of residues close to the active site. These ROS
could be generated either by the enzyme catalytic chemistry
itself or by redox side-reactions occurring in the assay mixture
whose products would di¡use to the active site. It is note-
worthy that the addition of catalase (0.5 mg/ml) has been
reported to substantially reduce enzyme inactivation (M.
Sami, unpublished work), and suggests the generation of hy-
drogen peroxide outside the catalytic site. However since the
catalase protection is incomplete it does not exclude active-
site-speci¢c formation of ROS.
The situation is very di¡erent in vivo where sophisticated
mechanisms may have evolved to sense and tightly regulate
any oxidative stress and where the concentration of free tran-
sition metals inside the cell is very low.
In conclusion, reliable enzymatic kinetic data rest on a pre-
cise and easy assay which preferentially allows a continuous
monitoring of the enzyme activity. We have developed such
an assay for IPNS which can be used to routinely monitor
enzymatic activity during puri¢cation or for precise analysis
of kinetic properties. The present assay, which is amenable to
automation with minor modi¢cations, has yielded kinetic pa-
rameters which are probably the most accurate yet reported.
Moreover, there is a broad interest in the economic, tech-
nical and social aspects of the production of L-lactam anti-
biotics and it is certainly valuable to gain a better access to
the in vitro kinetic properties of a key enzyme in their bio-
synthetic pathway.
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